Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -5.930% | -5.932% | -3.478% | 62.044% | -5.932% | -21.277% | -74.801% |
| Aurinia Pharmaceuticals Inc. | 0.700% | -1.690% | -5.115% | 70.213% | -4.974% | 52.272% | 16.258% |
| Spectral Medical Inc | - | 0.565% | 14.103% | 174.691% | 11.950% | 247.656% | 250.394% |
| Xenon Pharmaceuticals Inc. | 0.570% | -1.648% | -2.186% | -4.787% | -5.789% | 5.917% | - |
News
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave Signs Royalty-Bearing Commercial License with U.S. Snacking Company, Sells 10kW Radiant Energy Vacuum Machinery
Vancouver, B.C., November 10th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement

